188637-75-4 Usage
Uses
Used in Medicinal Chemistry:
2-Pyridinemethanamine,6-chloro-(9CI) is used as a building block in the synthesis of pharmaceuticals for its potential to contribute to the development of new drugs. Its unique structure, including the presence of a chlorine atom, may offer specific chemical reactivity and binding properties that are valuable in medicinal applications.
Used in Organic Synthesis:
In the field of organic synthesis, 2-Pyridinemethanamine,6-chloro-(9CI) serves as a precursor for the production of other chemical compounds. Its reactivity and functional groups make it a versatile intermediate in the creation of a variety of organic molecules.
Used in Chemical Research:
2-Pyridinemethanamine,6-chloro-(9CI) is utilized in chemical research to explore its properties and potential uses. This includes understanding its reactivity, stability, and how it can be modified or combined with other compounds to create new materials or products.
Check Digit Verification of cas no
The CAS Registry Mumber 188637-75-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,8,6,3 and 7 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 188637-75:
(8*1)+(7*8)+(6*8)+(5*6)+(4*3)+(3*7)+(2*7)+(1*5)=194
194 % 10 = 4
So 188637-75-4 is a valid CAS Registry Number.
188637-75-4Relevant articles and documents
Cyanophenyl derivative
-
Page column 18; 19, (2010/11/30)
This application relates to a piperazino-substituted novel cyanophenyl derivative in which a substituted carbamoyl or substituted sulfamoyl group having an aryl, heterocyclic or the like group that may have a substituent group is bonded to one nitrogen atom on the piperazine ring. The compound of this application has an anti-androgen action and is useful in preventing or treating prostatic cancer, benign prostatic hyperplasia and the like diseases.
CYANOPHENYL DERIVATIVES
-
, (2008/06/13)
This application relates to a piperazino-substituted novel cyanophenyl derivative in which a substituted carbamoyl or substituted sulfamoyl group having an aryl, heterocyclic or the like group that may have a substituent group is bonded to one nitrogen atom on the piperazine ring. The compound of this application has an anti-androgen action and is useful in preventing or treating prostatic cancer, benign prostatic hyperplasia and the like diseases.
